We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

News   Nov 28, 2017 | Original story from University of Illinois

 
Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

Pretzel's brain tumor shrank more than 40 percent after treatment with PAC-1 in a clinical trial for dogs with glioma, a brain cancer very similar to glioblastoma in humans. Credit: Photo courtesy Tim Fan

 
 
Advertisement
 

RELATED ARTICLES

Pilot Study Suggests the Feasibility of Convalescent Plasma Therapy for COVID-19

News

A pilot study suggests the feasibility of convalescent plasma (CP) therapy for treating COVID-19 patients. No specific antiviral treatments exist for SARS-CoV-2, the virus that causes COVID-19, creating a need for alternative treatment strategies.

READ MORE

Personalized Microrobots Deliver Drugs to Cells

News

Tiny biohybrid robots on the micrometer scale can swim through the body and deliver drugs to tumors or provide other cargo-carrying functions.

READ MORE

Genes Sow the Seeds of Psychiatric Disorders Before Birth

News

The seeds of neuropsychiatric illnesses and conditions such as autism spectrum disorder and schizophrenia may be sown during early prenatal development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE